SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) June 6, 2003
Inverness Medical Innovations, Inc.
(Exact Name of Registrant as Specified in Its Charter)
|
Delaware |
|
001-16789 |
|
04-3565120 |
|
(State
or other jurisdiction of |
|
(Commission file number) |
|
(IRS
Employer Identification |
|
|
|
|
|
|
|
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453 |
||||
|
(Address of principal executive offices) |
||||
|
|
||||
|
Registrant’s telephone number, including area code: (781) 647-3900 |
||||
|
|
||||
|
Not Applicable |
||||
|
(Former name or former address, if changed since last report) |
||||
ITEM 5. OTHER EVENTS
On June 6, 2003, we entered into a settlement agreement with a subsidiary of Pfizer, Inc. which resolves all of our patent infringement claims against Pfizer. In connection with the settlement one of our subsidiaries, Unipath, Ltd., has entered into a five year supply arrangement with Pfizer to supply its U.S. market leader E.P.T.® pregnancy tests, beginning in June, 2004. A copy of our press release dated June 9, 2003 announcing the settlement and supply arrangement is attached as Exhibit 99.1 to this Current Report on Form 8 K and incorporated by reference herein.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
c)
Exhibits. The following exhibits are filed with this document.
|
Exhibit Number |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated June 9, 2003, entitled “Inverness Medical Innovations Announces Settlement with Pfizer and Conference Call to discuss the Settlement” |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
INVERNESS MEDICAL INNOVATIONS, INC. |
|
|
|
|
|
|
|
|
|
BY: |
/s/ Paul T. Hempel |
|
|
|
|
Paul T. Hempel |
|
|
|
|
General Counsel & Secretary |
|
|
|
|
|
|
Dated: June 10, 2003 |
|
|
|
3
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated June 9, 2003, entitled “Inverness Medical Innovations Announces Settlement with Pfizer and Conference Call to discuss the Settlement” |
4